SCHEMBL24801882

SCHEMBL24801882

NCc1cccc2c1OCC2(F)F

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PNMT P11086 3/20 0.33
OPRL1 P41146 4/20 0.31
OPRM1 P35372 3/20 0.31
OPRD1 P41143 3/20 0.31
OPRK1 P41145 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL25389334 0.85 TAAR1 (0.38)
SCHEMBL22827426 0.83 PDK2 (0.37)
SCHEMBL21132537 0.73 KRAS (0.34)
SCHEMBL24343563 0.73
SCHEMBL24802168 0.72 SOS1 (0.36)
SCHEMBL28798525 0.70 SOS1 (0.39) PNMT
SCHEMBL22234725 0.70 PARP1 (0.49) OPRM1
SCHEMBL21132431 0.70 SOS1 (0.39) PNMT
SCHEMBL23344916 0.69 SOS1 (0.41)
SCHEMBL23995719 0.69 PTGS2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023098825-A1 SOS1 INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 勤浩医药(苏州)有限公司 2023-06-08 WO disclosed
WO-2022271679-A1 SOS1 INHIBITORS Mirati Therapeutics, Inc. (US) 2022-12-29 WO disclosed